What Vaxcyte, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 15 | 54 |
| Total trades | 38 | 120 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 123,382 | 506,004 |
| Disposed | 126,628 | 440,741 |
| Net activity | −3,246 | +65,263 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 05 | Open-market sale · S | −18,000 | $86.74 | −$1.56M | 145,435 |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 05 | Exercise / conversion · M | +18,000 | $5.35 | +$96.3K | 163,435 |
| Cowan Elvia | SVP, Finance & CAO | Oct 05 | Open-market sale · S | −19,000 | $86.74 | −$1.65M | 27,860 |
| Cowan Elvia | SVP, Finance & CAO | Oct 05 | Exercise / conversion · M | +19,000 | $25.92 | +$492K | 46,860 |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 01 | Open-market sale · S | −95 | $57.09 | −$5.42K | 145,435 |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 01 | Open-market sale · S | −2,155 | $56.65 | −$122K | 145,530 |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Oct 01 | Exercise / conversion · M | +2,250 | $5.35 | +$12K | 147,685 |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Sep 09 | Open-market sale · S | −1,334 | $59.52 | −$79.4K | 145,435 |
| Guggenhime Andrew | PRESIDENT AND CFO | Sep 08 | Withheld — tax / exercise cost · F | −7,155 | $60.36 | −$432K | 95,316 |
| Cowan Elvia | SVP, Finance & CAO | Sep 08 | Withheld — tax / exercise cost · F | −1,327 | $60.36 | −$80.1K | 27,860 |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Sep 08 | Withheld — tax / exercise cost · F | −5,459 | $60.36 | −$330K | 146,769 |
| Pickering Grant | CHIEF EXECUTIVE OFFICER | Sep 08 | Withheld — tax / exercise cost · F | −17,056 | $60.36 | −$1.03M | 429,902 |
| Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sep 08 | Withheld — tax / exercise cost · F | −7,651 | $60.36 | −$462K | 68,085 |
| Wassil Jim | EVP, Chief Scientific Ofc, COO | Sep 04 | Open-market sale · S | −1,381 | $61.16 | −$84.5K | 152,228 |
| Jodar Luis | Chief Medical Officer | Sep 04 | Grant / award · A | +52,632 | — | — | 52,632 |
| Guggenhime Andrew | PRESIDENT AND CFO | Sep 02 | Withheld — tax / exercise cost · F | −1,432 | $61.58 | −$88.2K | 102,471 |
| Cowan Elvia | SVP, Finance & CAO | Sep 02 | Withheld — tax / exercise cost · F | −326 | $61.58 | −$20.1K | 29,187 |
| Pickering Grant | CHIEF EXECUTIVE OFFICER | Sep 02 | Withheld — tax / exercise cost · F | −3,427 | $61.58 | −$211K | 446,958 |
| Dhaliwal Harpreet S. | Chief Technical Ops Officer | Sep 02 | Withheld — tax / exercise cost · F | −659 | $61.58 | −$40.6K | 75,736 |
| Wassil Jim | CHIEF OPERATING OFFICER | Sep 02 | Withheld — tax / exercise cost · F | −1,432 | $61.58 | −$88.2K | 153,609 |
Loading...
